2 terminated, 1 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Recurrent Non-Small Cell Lung Carcinoma: new trials by email Literature Review of Recurrent Non-Small Cell Lung Carcinoma trials Research Report on Recurrent Non-Small Cell Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Afatinib Dimaleate, Cetuximab, Laboratory Biomarker Analysis - Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | Completed | SWOG Cancer Research Network | 174 | 2015-05-07 | 2026-05-18 |
| Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer Erlotinib Hydrochloride, Pemetrexed Disodium - Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer | Phase 3 | Terminated | National Cancer Institute (NCI) | 23 | 2008-10-01 | 2015-10-29 |
| Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer 3-Dimensional Conformal Radiation Therapy, Erlotinib Hydrochloride, Stereotactic Radiosurgery - Metastatic Malignant Neoplasm in the Brain, Recurrent Non-Small Cell Lung Carcinoma | Phase 3 | Terminated | National Cancer Institute (NCI) | 126 | 2004-10-06 | 2018-03-09 |
Carcinoma, Non-Small-Cell Lung (3) · Brain Neoplasms (1)
Bronchial Neoplasms (3) · Carcinoma, Bronchogenic (3) · Lung Diseases (3) · Lung Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
Erlotinib Hydrochloride (2) · Afatinib (1) · Cetuximab (1) · Pemetrexed (1) · Radiosurgery (1) · Radiotherapy, Conformal (1) · Temozolomide (1)
National Cancer Institute (NCI) (2) · SWOG Cancer Research Network (1)
United States (3) · Canada (2)
Alex Adjei (1) · Paul Sperduto (1) · Sarah Goldberg (1)
U10CA021661 (1), U10CA025224 (1), U10CA180821 (1), U10CA180888 (1)